FDA Publicizes Philips Azurion Recall in October 2026: Undocumented Solid-State Drives Affected 9 Models and 4,304 Units

FDA Publicizes Philips Azurion Correction in October 2026

On October 27, 2026, the U.S. Food and Drug Administration (FDA) Device Recall database publicized a correction action for angiography systems. Philips Medical Systems Nederland B.V. in the Netherlands issued a registered letter to customers on October 6, 2026, titled “URGENT Medical Device Correction.” The database split the action into 9 records, numbered Z-0292-2027 through Z-0300-2027, all under event number 99939, covering Azurion 3, Azurion 5, Azurion 7 and Azurion S.

The Issue Is Not the Imaging Chain but the Hard Drive

The company’s stated cause is specific: some system computers (PCs) may have solid-state drives (SSDs) installed that are not documented in the Medical Device File. The performance characteristics of these drives are inconsistent with design specifications, and reliability may decline over time. Typical manifestations include loss of imaging function, failure of motorized gantry movement, black or blank display screens, inability to save newly acquired images, and inability to retrieve previously stored images. The “root cause category” field in the database is Equipment maintenance, pointing to installation and servicing rather than a batch defect in the components themselves. The record status is Open, Classified.

Nine Models and More Than 4,000 Units

By series, the quantities are: Azurion 3 M12 and 3 M15, 95 and 519 units respectively; Azurion 5 M12 and 5 M20, 60 and 465 units respectively; the four Azurion 7 models, 209, 457, 602 and 1,896 units in that order; and Azurion S, 1 unit. The nine entries total 4,304 units. Azurion 7 M20 is the largest single entry, accounting for nearly half of the total.

The corresponding model numbers are 722063, 722221, 722064, 722222, 722280, 722227, 722228, 722281, 722067, 722225, 722068, 722226, 722078, 722223, 722079, 722224, 722282 and 722285.

The distribution scope is listed as the entire United States and multiple countries and regions including China and Japan. Because the installed base is spread across dozens of markets, a spare-part issue in the same batch of components would not be limited to the United States.

The Action Is Use-While-Correcting, Not Immediate Shutdown

The company requires that affected systems may continue to be used in accordance with the instructions for use and the supplemental instructions attached to the letter, and provides a degraded-operation path: if motorized movement is unavailable, the handles and brakes on both sides of the gantry can be used to adjust position manually; for ceiling-mounted systems, longitudinal, lateral and rotational movements can still be performed manually, with lateral movement available only on ceiling-mounted systems equipped with the FlexMove option. This point merits attention: interventional catheterization laboratories are environments where arbitrary shutdown is not practical, and both regulators and the company tend to preserve usability first and arrange correction afterward. However, “may continue to be used” does not mean “no action is required”; an inability to save or retrieve images has a direct impact on intraoperative decision-making.

The Key Phrase Is “Not Documented in the Medical Device File”

The Medical Device File is the term used in the ISO 13485 system for the technical documentation of an individual device or device family, covering specifications, drawings, purchasing requirements, and production and service requirements. If a company’s actual installed configuration does not match what is written in the file, the problem is not the hard drive but the two control points of change control and purchasing control: during service replacement, generic IT parts were substituted for the specified model without an equivalence assessment and without writing the replacement configuration back into the file. The U.S. Quality Management System Regulation (QMSR), effective in 2026, incorporates ISO 13485 by reference. This type of deviation—actual configuration inconsistent with the file—is an objective evidence gap that is likely to be questioned in a system audit.

Three Reminders for Chinese Exporters

• After-sales and spare-parts lists must follow the registration dossier. If the imaging workstation of the same model changes hard-drive brand or specification, whether safety and performance are affected requires a traceable assessment record, not merely a line in a service work order stating “replaced.”
• Part replacement by third-party service providers and distributors must be controlled. Products with a large overseas installed base and dispersed service sites are most prone to local repair practices of “install whatever is on hand.”
• Do not treat “may continue to be used” as the conclusion. This is a use condition issued by the company after assessing risk, together with manual fallback operations; users still need to check the model and serial number unit by unit against the letter to confirm whether their systems are in scope.

Sources and Scope Note

Sources: U.S. Food and Drug Administration (FDA) Device Recall database public interface records, event number 99939, recall numbers Z-0292-2027 through Z-0300-2027, publicized October 27, 2026, recall initiation date October 6, 2026.

https://api.fda.gov/device/recall.json?search=res_event_number:%2299939%22

https://api.fda.gov/device/recall.json?search=product_res_number:%22Z-0299-2027%22&limit=1

Verification scope and access date: this verification read the 9 recall records returned by the above interface and checked item by item the model, quantity, reason, corrective action, root cause category and distribution scope; the access date was November 4, 2026. The article does not cite media paraphrases and does not infer recall classification conclusions not provided by the database.

Applicability note: this article is an interpretation of public regulatory information and does not constitute conclusions or commitments regarding any specific product, company or registration application. The specific scope is subject to the official original text and the company’s correction letter, and the information may change with subsequent official updates.

AIMEILI Regulatory Interpretation

The central regulatory issue in this correction is configuration control and documentation consistency. The database identifies the root cause category as Equipment maintenance, which directs attention to service and replacement activities rather than to the imaging chain itself. For manufacturers, a component installed during service must remain within the approved configuration, or the change must be evaluated, approved and documented. Under ISO 13485 and the U.S. QMSR, purchasing control, change control, service records and technical documentation must be consistent; an SSD that is not in the Medical Device File is therefore a documentation and change-control gap, not merely a spare-part sourcing issue.

The action also shows how field corrections are communicated. The company issued an urgent medical device correction letter on October 6, 2026, and the FDA database publicized the records on October 27, 2026. The records are split by model and carry a common event number, which allows regulators and customers to track the scope across multiple product entries. Manufacturers facing similar service-part deviations should assess whether the actual installed configuration differs from the approved file, whether an equivalence assessment exists, and whether customer notification and regulatory reporting obligations have been met.

Business Impact

• Service and spare-parts governance: Manufacturers and authorized service providers should review spare-part specifications, supplier qualification and equivalence assessments for imaging workstations and other installed systems. Replacement parts should be traceable to the approved configuration.
• Distributor and third-party service oversight: Contracts, training and repair procedures should prevent local service teams from installing generic IT components without approval. Service work orders should record the approved part number and any deviation assessment.
• Installed-base reconciliation: Companies should be able to map affected models and serial numbers to customers and markets. The Philips records cover the United States and multiple countries including China and Japan, so a single spare-part issue can require multi-market customer communication.
• Audit readiness: Auditors may ask for evidence that actual configuration matches the Medical Device File and that changes were controlled. Missing records can become objective evidence gaps under ISO 13485 and QMSR inspections.
• Customer communication and continuity: Where continued use is permitted with manual fallback, instructions must be clear and verifiable. Users still need to confirm whether their systems are in scope and follow the correction letter.